https://synopulse.com/nhs-gives-green-light-to-life-changing-sma-treatments/ 2026-05-15T16:55:16+00:00 https://synopulse.com/eu-critical-medicines-act-fights-dangerous-supply-crisis/ 2026-05-11T21:08:52+00:00 https://synopulse.com/february-2026-deal-report-five-signals-from-53b-in-activity/ 2026-03-01T18:20:40+00:00 https://synopulse.com/lilly-to-buy-ventyx-for-1-2b-bolstering-oral-inflammation-pipeline/ 2026-01-08T08:16:29+00:00 https://synopulse.com/nice-backs-digital-asthma-tools-for-nhs-use-as-evidence-builds/ 2026-01-08T05:00:00+00:00 https://synopulse.com/iqwig-highlights-evidence-gaps-despite-growing-treatment-options/ 2026-01-08T04:26:15+00:00 https://synopulse.com/lilly-taps-indupros-proximity-guided-platform-in-up-to-950m-oncology-deal/ 2026-01-08T04:03:32+00:00 https://synopulse.com/lilly-in-advanced-talks-to-buy-ventyx-in-deal-topping-1b/ 2026-01-08T03:52:58+00:00 https://synopulse.com/neuropulse-daily-january-8-2026/ 2026-01-08T03:37:06+00:00 https://synopulse.com/neuropulse-daily-january-7-2026/ 2026-01-07T01:00:00+00:00 https://synopulse.com/lilly-reups-with-nimbus-in-1-3b-oral-obesity-deal/ 2026-01-07T01:30:00+00:00 https://synopulse.com/ikarovec-eyes-1b-deal-to-move-eye-gene-therapy-in-office/ 2026-01-07T00:30:00+00:00 https://synopulse.com/neuropulse-daily-january-05-2026/ 2026-01-06T08:29:44+00:00 https://synopulse.com/nice-clears-ms-treatment-option-suitable-during-pregnancy/ 2026-01-06T07:36:29+00:00 https://synopulse.com/nice-backs-age-based-blood-test-to-spot-ovarian-cancer/ 2026-01-06T06:32:21+00:00 https://synopulse.com/sanofi-earendil-lab-ink-2-5b-deal-for-bispecific-antibody/ 2026-01-05T16:40:51+00:00 https://synopulse.com/abbvie-bets-1-2b-on-zelgens-dll3-trispecific/ 2026-01-05T05:38:30+00:00 https://synopulse.com/neuropulse-todays-signals-personalized-neuromodulation-pediatric-imaging-wins-and-schizophrenia-ip-resets/ 2025-12-20T01:30:00+00:00 https://synopulse.com/neuropulse-daily-brief-december-20-2025/ 2025-12-20T00:30:00+00:00 https://synopulse.com/germany-updates-meningococcal-shingles-vaccine-policy-for-2026/ 2025-12-20T03:01:00+00:00 https://synopulse.com/eu-finalizes-landmark-pharma-reform-to-reset-access-and-incentives/ 2025-12-20T02:01:00+00:00 https://synopulse.com/biomarin-to-acquire-amicus-for-4-8b-in-rare-disease-deal/ 2025-12-20T01:00:00+00:00 https://synopulse.com/cms-confirms-2026-coverage-for-mtfs-amnioband-allopatch/ 2025-12-19T03:00:00+00:00 https://synopulse.com/netherlands-moves-to-cut-mental-health-wait-times-for-2026/ 2025-12-19T02:30:00+00:00 https://synopulse.com/biostem-lands-2026-cms-status-quo-coverage-for-skin-grafts/ 2025-12-19T02:00:00+00:00 https://synopulse.com/envues-uroshield-secures-uk-nhs-reimbursement/ 2025-12-19T01:00:00+00:00 https://synopulse.com/neuropulse-daily-brief-december-19-2025/ 2025-12-19T00:30:00+00:00 https://synopulse.com/neuropulse-todays-signals-precision-regulation-rna-partnerships-and-real-world-data-redefine-neuro-strategy/ 2025-12-19T01:30:00+00:00 https://synopulse.com/neuropulse-daily-summary-december-18-2025/ 2025-12-18T00:30:00+00:00 https://synopulse.com/neuropulse-todays-signals-fda-clears-kpap-rns-pushes-into-generalized-epilepsy/ 2025-12-18T01:30:00+00:00 https://synopulse.com/medline-raises-6-26b-in-2025s-biggest-ipo/ 2025-12-18T03:00:00+00:00 https://synopulse.com/cms-reopens-national-tavr-coverage-review-at-edwards-request/ 2025-12-18T01:00:00+00:00 https://synopulse.com/bms-signs-1-1b-multispecific-antibody-deal-with-harbour/ 2025-12-17T06:52:17+00:00 https://synopulse.com/genentech-strikes-1-1b-cancer-ai-deal-with-caris/ 2025-12-17T02:00:00+00:00 https://synopulse.com/icer-backs-wegovy-zepbound-value-in-obesity-but-flags-access-crunch/ 2025-12-17T01:30:00+00:00 https://synopulse.com/zealand-otr-sign-up-to-2-5b-metabolic-drug-deal/ 2025-12-17T00:30:00+00:00 https://synopulse.com/yarrow-snags-1-37b-tshr-thyroid-drug-from-gensci/ 2025-12-16T20:47:09+00:00 https://synopulse.com/neuropulse-daily-fda-resets-ms-setback-ar-neurosurgery-gains/ 2025-12-17T01:00:00+00:00 https://synopulse.com/sanofi-stacks-alzheimers-bet-with-second-biotech-deal-of-the-day-lining-up-1b-plus-tau-antibody-pact/ 2025-12-16T08:56:48+00:00 https://synopulse.com/dren-bio-sanofi-expand-1-8b-b-cell-depletion-alliance/ 2025-12-15T19:00:00+00:00 https://synopulse.com/sobi-buys-arthrosi-to-broaden-gout-franchise-and-push-into-chronic-inflammation/ 2025-12-15T17:01:57+00:00 https://synopulse.com/eu-greenlights-landmark-pharma-package-overhauling-drug-rules-for-the-first-time-in-20-years/ 2025-12-12T03:00:00+00:00 https://synopulse.com/icer-advances-two-high-stakes-assessments-cytisinicline-cleared-igan-therapies-under-review/ 2025-12-12T02:00:00+00:00 https://synopulse.com/neuropulse-daily-summary-regulatory-momentum-clinical-expansion-and-next-gen-neurotech-gain-pace/ 2025-12-12T01:00:00+00:00 https://synopulse.com/teleflex-sells-three-business-units-in-2b-portfolio-shift/ 2025-12-11T03:00:00+00:00 https://synopulse.com/uk-cuts-vpag-newer-medicine-rate-to-14-5-for-2026/ 2025-12-11T02:00:00+00:00 https://synopulse.com/neuropulse-daily-lumosityrx-secures-fda-nod-and-inteligex-drives-sci-regeneration-push/ 2025-12-11T01:00:00+00:00 https://synopulse.com/neuropulse-daily-dmd-trial-distal-stroke-data-lecanemab-access/ 2025-12-10T00:30:00+00:00 https://synopulse.com/novartis-inks-1-7-billion-skin-disease-pact-with-ai-startup-relation/ 2025-12-10T03:00:00+00:00 https://synopulse.com/pfizer-and-yaopharma-forge-2-1b-alliance-to-advance-oral-glp-1-drug/ 2025-12-10T02:00:00+00:00 https://synopulse.com/freenome-to-go-public-in-1-1b-spac-deal-backed-by-perceptive-and-ra-capital/ 2025-12-09T03:00:00+00:00 https://synopulse.com/chinas-2026-nrdl-drives-major-breakthroughs-in-drug-access/ 2025-12-09T02:00:00+00:00 https://synopulse.com/german-court-halts-mercks-keytruda-sc-in-major-patent-clash/ 2025-12-09T01:00:00+00:00 https://synopulse.com/neuropulse-daily-breakthroughs-across-parkinsons-epilepsy-and-trs/ 2025-12-09T00:30:00+00:00 https://synopulse.com/weekly-pulse-policy-access-rules-rewritten-for-2026/ 2025-12-08T03:00:00+00:00 https://synopulse.com/seven-nrdl-wins-position-innovent-for-volume-driven-growth-in-2025/ 2025-12-07T19:31:12+00:00 https://synopulse.com/g-ba-clears-2026-launch-of-biologic-substitution-rules/ 2025-12-05T03:00:00+00:00 https://synopulse.com/white-house-and-london-clinch-drug-pricing-deal-with-25-uk-price-lift/ 2025-12-03T03:00:00+00:00 https://synopulse.com/neuropulse-daily-advancing-the-alzheimers-battle-with-early-detection-and-novel-mechanisms/ 2025-12-03T02:00:00+00:00 https://synopulse.com/cms-sets-1352-payment-rate-for-pillars-oncoreveal-cdx/ 2025-12-02T03:00:00+00:00 https://synopulse.com/tissiums-de-novo-fda-authorization-signals-industry-shift/ 2025-12-01T19:13:52+00:00 https://synopulse.com/sintx-enters-the-1-3b-foot-and-ankle-implants-market-with-sinaptic-acquisition/ 2025-12-01T19:13:08+00:00 https://synopulse.com/ncpe-recommends-vabysmo-signaling-retinal-policy-shift/ 2025-12-01T19:12:18+00:00 https://synopulse.com/sanofis-tzield-receives-fda-expedited-review/ 2025-12-01T19:12:00+00:00 https://synopulse.com/baird-medical-secures-reimbursement-win-for-mwa/ 2025-12-01T19:10:37+00:00 https://synopulse.com/novo-nordisk-cuts-wegovy-and-ozempic-self-pay-price-to-199-in-new-access-push/ 2025-12-01T19:04:49+00:00 https://synopulse.com/b-braun-settled-with-over-faulty-knee-implant/ 2025-12-01T19:01:01+00:00 https://synopulse.com/concertais-terarecon-launches-detect-to-align-ai-imaging-with-reimbursement-and-clinical-workflow/ 2025-12-01T18:55:39+00:00 https://synopulse.com/neuropulse-daily-key-moves-in-fragile-x-menieres-dmd-alzheimers-detection-and-gmg-access/ 2025-12-02T02:00:00+00:00 https://synopulse.com/korea-unlocks-breakthrough-access-for-ultomiris-and-jemperli/ 2025-12-02T00:30:00+00:00 https://synopulse.com/novo-nordisk-secures-breakthrough-masp-3-asset-in-2-1b-omeros-deal/ 2025-12-02T01:00:00+00:00 https://synopulse.com/merck-canada-and-pcpa-complete-winrevair-negotiations-advancing-public-reimbursement-pathway-for-pah/ 2025-12-01T15:27:38+00:00 https://synopulse.com/neuropulse-daily-reimbursement-shifts-als-sma-trial-momentum-and-next-gen-imaging-robotic-spine-innovations/ 2025-12-01T15:00:21+00:00 https://synopulse.com/neuropulse-daily-cms-stability-primec-phase-3-approval-and-next-gen-ct-imaging-momentum/ 2025-12-01T14:59:36+00:00 https://synopulse.com/neuropulse-daily-next-gen-ai-imaging-debuts-als-trial-readiness-builds-and-cms-boosts-neurostimulation-payments/ 2025-12-01T14:58:46+00:00 https://synopulse.com/synopulse-weekly-pulse-access-decisions-regulatory-events-market-dynamics-week-of-nov-10-2025/ 2025-12-01T14:51:50+00:00 https://synopulse.com/synopulse-weekly-pulse-access-decisions-regulatory-events-market-dynamics-week-of-nov-17-2025/ 2025-12-01T14:51:02+00:00 https://synopulse.com/repatha-shows-sustained-cv-benefit-in-largest-rwe-study/ 2025-12-01T14:44:40+00:00 https://synopulse.com/pacira-sues-to-block-exparel-generics-after-anda-filings/ 2025-12-01T14:37:38+00:00 https://synopulse.com/weekly-pulse-access-decisions-regulatory-events-market-dynamics-week-of-nov-24-2025/ 2025-12-01T14:36:59+00:00 https://synopulse.com/ai-wearable-episeras-predicts-seizures-in-real-time/ 2025-12-01T14:35:58+00:00 https://synopulse.com/global-reimbursement-momentum-shifts-market-dynamics-across-immunology-and-oncology/ 2025-12-01T02:00:00+00:00 https://synopulse.com/cms-unveils-2027-negotiated-prices-delivering-major-savings-across-15-drugs/ 2025-11-27T00:30:00+00:00 https://synopulse.com/cms-medicaid-expand-2026-coverage-for-five-emerging-health-technologies/ 2025-11-27T01:00:00+00:00 https://synopulse.com/hitap-launches-global-research-unit-to-strengthen-evidence-informed-health-policy-across-lmics/ 2025-11-26T02:00:00+00:00 https://synopulse.com/france-strengthens-cancer-access-with-tevimbra-and-new-14-day-trial-fast-track/ 2025-11-26T01:30:00+00:00 https://synopulse.com/nice-issues-two-major-2025-approvals-vutrisiran-for-attr-cm-and-aucatzyl-car-t-for-r-r-b-all/ 2025-11-26T01:00:00+00:00 https://synopulse.com/cms-sets-new-medicare-2026-rates-across-five-innovation-categories/ 2025-11-26T00:30:00+00:00 https://synopulse.com/nice-recommends-nanox-ais-spine-fracture-detection-tools-for-early-value-assessment-across-nhs-hospitals/ 2025-11-25T02:00:00+00:00 https://synopulse.com/cms-finalizes-saint-payment-stability-and-major-reimbursement-gains-for-neuropaces-rns-system/ 2025-11-25T01:00:00+00:00 https://synopulse.com/ge-healthcare-to-acquire-intelerad-for-2-3b-to-build-a-cloud-first-enterprise-imaging-platform/ 2025-11-24T02:00:00+00:00 https://synopulse.com/germany-updates-emergency-care-tiers-as-iqwig-questions-daratumumab-benefit-in-smoldering-myeloma/ 2025-11-21T03:00:00+00:00 https://synopulse.com/nice-issues-new-updates-on-ai-cancer-detection-sepsis-care-and-breast-cancer-drug-appraisal/ 2025-11-21T01:00:00+00:00 https://synopulse.com/cms-sets-national-pricing-for-vesiflos-inflow-device-expanding-access-for-women-with-permanent-urinary-retention/ 2025-11-21T02:00:00+00:00 https://synopulse.com/neuropulse-daily-aspn-pns-guideline-headlines-a-busy-day-of-deals-diagnostics-and-neurotechnology-progress/ 2025-11-21T00:30:00+00:00 https://synopulse.com/valo-health-merck-kgaa-launch-3b-collaboration-targeting-parkinsons-disease/ 2025-11-20T19:28:46+00:00 https://synopulse.com/neuropulse-daily-clinical-discovery-device-updates/ 2025-11-20T00:30:00+00:00 https://synopulse.com/alkermes-raises-avadel-acquisition-offer-to-2-37b/ 2025-11-20T01:00:00+00:00 https://synopulse.com/minnesota-seeks-1b-for-rural-health-transformation/ 2025-11-20T03:00:00+00:00 https://synopulse.com/philips-debuts-deviceguide-to-enhance-real-time-navigation/ 2025-11-19T04:18:17+00:00 https://synopulse.com/iqwig-no-added-benefit-for-darolutamide-vs-apalutamide/ 2025-11-19T02:00:00+00:00 https://synopulse.com/cms-sets-2026-medicare-premiums-and-deductibles/ 2025-11-19T01:00:00+00:00 https://synopulse.com/nice-expands-cancer-and-dermatology-options-with-three-major-recommendations-across-dlbcl-myeloma-and-chronic-hand-eczema/ 2025-11-19T00:30:00+00:00 https://synopulse.com/vietnam-targets-2026-rollout-of-free-annual-health-checks-and-expanded-insurance-coverage/ 2025-11-18T04:36:44+00:00 https://synopulse.com/jjs-3b-halda-deal-sets-up-50b-oncology-push/ 2025-11-18T00:30:00+00:00 https://synopulse.com/biogens-high-dose-nusinersen-wins-chmp-backing/ 2025-11-18T03:00:00+00:00 https://synopulse.com/ema-chmp-november-2025-meeting-ten-new-approvals-four-indication-extensions/ 2025-11-17T02:00:00+00:00 https://synopulse.com/uk-vpag-decision-deadline-extended-again/ 2025-11-17T01:00:00+00:00 https://synopulse.com/us-cuts-swiss-tariffs-to-15-as-switzerland-pledges-200b-investments/ 2025-11-16T14:36:40+00:00 https://synopulse.com/abl-bios-grabody-lands-2-6b-deal-with-lilly/ 2025-11-14T17:05:00+00:00 https://synopulse.com/cidara-therapeutics-9b-merck-buyout/ 2025-11-14T15:35:24+00:00 https://synopulse.com/spain-expands-newborn-screening-portfolio-and-launches-national-asbestos-injury-certification-in-dual-public-health-overhaul/ 2025-11-14T02:00:00+00:00 https://synopulse.com/fda-unveils-pathway-for-gene-editing-therapies/ 2025-11-13T04:01:18+00:00 https://synopulse.com/icer-releases-draft-scope-on-covid-19-vaccines/ 2025-11-12T02:00:00+00:00 https://synopulse.com/lilly-alliances-genetic-medicines-with-rnai-gene-therapy/ 2025-11-11T02:00:00+00:00 https://synopulse.com/tlv-endorses-cost-effectiveness-for-keytruda/ 2025-11-11T01:00:00+00:00 https://synopulse.com/pfizer-wins-10-billion-bidding-war-for-metsera/ 2025-11-10T02:26:33+00:00 https://synopulse.com/us-launches-medicaid-drug-payment-model-bring-mfn/ 2025-11-10T02:26:08+00:00 https://synopulse.com/fda-unveils-second-wave-of-national-priority-voucher/ 2025-11-10T03:00:00+00:00 https://synopulse.com/dutch-institute-limits-access-obesity-drugs-amid-cost-and-evidence-concerns/ 2025-11-07T02:55:00+00:00 https://synopulse.com/novo-nordisk-clears-hurdle-in-10b-metsera-takeover/ 2025-11-07T01:00:00+00:00 https://synopulse.com/thailand-drug-access-program-slash-bills-by-32b-baht/ 2025-11-07T02:00:00+00:00 https://synopulse.com/scilex-secures-global-license-for-datavault-platform/ 2025-11-06T03:05:51+00:00 https://synopulse.com/obesity-drug-talks-lilly-and-novo-trump-deal/ 2025-11-06T02:51:02+00:00 https://synopulse.com/metsera-board-declares-novo-nordisk-takeover-battle/ 2025-11-06T02:00:00+00:00 https://synopulse.com/340b-rebate-model-pilot-clears-hrsa-approval/ 2025-11-05T03:00:00+00:00 https://synopulse.com/healthcare-reimbursement-cms-promises-major-savings/ 2025-11-05T02:30:00+00:00 https://synopulse.com/bone-cement-treatment-boosts-metastatic-cancer/ 2025-11-05T02:00:00+00:00 https://synopulse.com/lepu-licenses-triple-agonist-platform-to-sidera-bio/ 2025-11-05T01:30:00+00:00 https://synopulse.com/manifold-bio-and-roche-launch-2b-plus-collaboration/ 2025-11-05T01:00:00+00:00 https://synopulse.com/united-states-and-malaysia-reciprocal-trade-deal/ 2025-11-05T00:30:00+00:00 https://synopulse.com/metsera-responds-to-pfizer-lawsuit/ 2025-11-04T19:51:03+00:00 https://synopulse.com/regeneron-unlocks-multispecific-antibody-pact/ 2025-11-04T19:50:11+00:00 https://synopulse.com/exquisite-breakthroughs-in-personalized-gene-editing/ 2025-11-04T02:30:00+00:00 https://synopulse.com/lifescience-weekly-digest-key-industry-updates-13th-17th-january/ 2025-11-03T20:25:45+00:00 https://synopulse.com/strategic-industry-context-alzheimers-drug-reimbursement-faces-global-pressure/ 2025-11-03T20:24:13+00:00 https://synopulse.com/nice-guidance-catalyzes-digital-mental-health-innovation/ 2025-11-03T20:23:35+00:00 https://synopulse.com/nice-expands-tavi-guidance-for-aortic-valve-regurgitation/ 2025-11-03T20:23:26+00:00 https://synopulse.com/south-koreas-drug-pricing-reforms-reshape-market-access-landscape/ 2025-11-03T20:23:08+00:00 https://synopulse.com/judge-rules-rewalk-device-is-medically-necessary-for-medicare/ 2025-11-03T20:22:56+00:00 https://synopulse.com/new-reimbursement-strategy-boosts-ambulatory-pay/ 2025-11-03T20:22:46+00:00 https://synopulse.com/ncpe-recommends-conditional-access-for-omeprazole/ 2025-11-03T20:22:03+00:00 https://synopulse.com/focus-brief-market-access-weekly-september-1-to-7-2025/ 2025-11-03T20:21:51+00:00 https://synopulse.com/poland-makes-historic-leap-in-healthcare-record-number-of-new-therapies-now-reimbursed/ 2025-11-03T20:21:39+00:00 https://synopulse.com/nice-accelerates-breakthrough-framework-for-diseases/ 2025-11-03T20:21:22+00:00 https://synopulse.com/nice-secures-hta-decision-for-prostate-cancer/ 2025-11-03T20:21:11+00:00 https://synopulse.com/swedens-reimbursement-shift-spurs-biotech/ 2025-11-03T20:21:02+00:00 https://synopulse.com/has-update-transforms-stroke-care-pathway-access/ 2025-11-03T20:20:52+00:00 https://synopulse.com/thermofisher-takeover-of-clario-for-10-billion/ 2025-11-03T20:20:44+00:00 https://synopulse.com/uk-government-game-changing-drug-pricing-strategy/ 2025-11-03T20:20:21+00:00 https://synopulse.com/evernorth-secures-pricing-shift-in-drug-access/ 2025-11-03T20:19:59+00:00 https://synopulse.com/new-proposal-calls-for-funeral-reimbursement/ 2025-11-03T20:19:49+00:00 https://synopulse.com/cms-and-europe-reimbursement-pathway/ 2025-11-03T20:19:25+00:00 https://synopulse.com/stricter-iqwig-stance-on-cardiac-mri-endpoints/ 2025-11-03T20:18:56+00:00 https://synopulse.com/novos-unsolicited-bid-for-metsera-challenges-pfizer/ 2025-11-03T01:00:00+00:00 https://synopulse.com/icer-final-report-puts-brensocatib-value-to-the-test/ 2025-11-03T01:30:00+00:00 https://synopulse.com/sprouts-launches-lawsuit-challenging-insulin-pricing/ 2025-10-30T02:30:00+00:00 https://synopulse.com/novartis-secures-12-billion-takeover-of-avidity/ 2025-10-28T01:00:00+00:00 https://synopulse.com/biogen-vanqua-immunology-1b-deal/ 2025-10-27T02:30:00+00:00 https://synopulse.com/pfizer-throws-down-7-3b-gauntlet-in-obesity-race-with-metsera-buyout/ 2025-09-23T01:29:51+00:00 https://synopulse.com/fdas-bsufa-iii-framework-what-it-means-for-biosimilar-sponsors/ 2025-09-10T02:30:00+00:00 https://synopulse.com/the-big-bet-health-care-deal-spotlight-for-september-1-to-7-2025/ 2025-09-08T02:30:00+00:00 https://synopulse.com/wp-content/uploads/2025/09/Deal-Split-September-1st-to-7th-1.png https://synopulse.com/wp-content/uploads/2025/09/Deal-Split-Ratio-September-1st-to-7th-1.png https://synopulse.com/jj-launches-ai-in-surgery-funding-via-polyphonic-fund/ 2025-06-27T06:30:00+00:00 https://synopulse.com/strykers-incompass-total-ankle-wins-fda-clearance/ 2025-06-27T06:00:00+00:00 https://synopulse.com/kymera-strikes-license-agreement-deals-with-sanofi-gilead/ 2025-06-27T06:00:00+00:00 https://synopulse.com/hereditary-angioedema-drug-from-csl-gains-german-backing/ 2025-06-27T05:30:00+00:00 https://synopulse.com/fda-import-ban-disrupts-olympus-us-medical-supply/ 2025-06-27T05:00:00+00:00 https://synopulse.com/vor-bio-and-remegen-seal-4b-global-license-agreement/ 2025-06-27T04:04:32+00:00 https://synopulse.com/novartis-inks-750m-flagship-pact-for-cardio-innovation/ 2025-06-27T03:59:30+00:00 https://synopulse.com/fda-probes-elevidys-deaths-stirring-regulatory-and-market-uncertainty/ 2025-06-26T03:30:00+00:00 https://synopulse.com/gilead-taps-kymera-in-750m-oncology-deal-to-harness-molecular-glue-degraders/ 2025-06-26T03:00:00+00:00 https://synopulse.com/neuron23s-neu-411-trial-shifts-the-parkinsons-paradigm-toward-precision/ 2025-06-26T02:30:00+00:00 https://synopulse.com/benlysta-autoinjector-approval-transforming-pediatric-lupus-nephritis-management/ 2025-06-25T05:30:00+00:00 https://synopulse.com/digital-pathology-clearance-accelerates-u-s-market-entry/ 2025-06-25T04:30:00+00:00 https://synopulse.com/revolution-medicines-secures-powerhouse-2b-funding-in-groundbreaking-royalty-pharma-deal/ 2025-06-25T03:30:00+00:00 https://synopulse.com/arialys-therapeutics-targets-first-in-class-precision-therapy-for-autoimmune-encephalitis/ 2025-06-23T05:30:00+00:00 https://synopulse.com/enhertu-advances-first-line-endometrial-therapy-in-phase-3-trial/ 2025-06-10T09:30:00+00:00 https://synopulse.com/alexion-strikes-bold-ai-partnership-for-rare-disease-detection/ 2025-06-10T06:30:00+00:00 https://synopulse.com/zeiss-clarus-700-gains-china-nmpa-approval-for-retinal-imaging/ 2025-06-10T05:30:00+00:00 https://synopulse.com/goodrx-disrupts-pharmacy-economics-with-cost-plus-pricing/ 2025-06-10T04:30:00+00:00 https://synopulse.com/ema-links-semaglutide-to-rare-vision-loss-risk/ 2025-06-09T09:30:00+00:00 https://synopulse.com/dupixent-shows-efficacy-in-diverse-patient-population/ 2025-06-09T06:00:00+00:00 https://synopulse.com/redetsa-convenes-38-hta-institutions-for-americas-summit/ 2025-06-09T03:49:14+00:00 https://synopulse.com/unitedhealth-humana-back-medicare-home-visit-reforms/ 2025-06-09T04:00:00+00:00 https://synopulse.com/simplify-healthcare-captures-30-medicare-advantage-market-share/ 2025-06-09T03:30:00+00:00 https://synopulse.com/medacta-showcases-advanced-orthopedic-solutions-at-isakos/ 2025-06-09T10:30:00+00:00 https://synopulse.com/owens-minor-scraps-1-4b-rotech-deal-amid-ftc-opposition/ 2025-06-09T07:00:00+00:00 https://synopulse.com/medtronic-issues-class-i-recall-for-tracheostomy-tubes/ 2025-06-09T05:00:00+00:00 https://synopulse.com/jj-faces-442m-treble-damages-over-catheter-monopoly/ 2025-06-09T04:30:00+00:00 https://synopulse.com/synopulse-weekly-top-deals-fda-moves-pricing-insights/ 2025-06-09T02:56:34+00:00 https://synopulse.com/venteur-announces-strategic-partnership-with-united-benefit-advisors-to-provide-personalized-insurance-solutions-to-employers-nationwide/ 2025-06-08T17:57:42+00:00 https://synopulse.com/stratipath-and-roche-collaborate-to-expand-access-to-ai-powered-breast-cancer-diagnostics/ 2025-06-08T17:57:35+00:00 https://synopulse.com/a-menarini-diagnostics-and-nucleix-form-strategic-partnership-for-non-invasive-bladder-cancer-test-in-europe/ 2025-06-08T17:57:27+00:00 https://synopulse.com/eqt-to-acquire-gebbs-healthcare-solutions/ 2025-06-08T17:57:20+00:00 https://synopulse.com/kalsi-insurance-partners-with-integrity-to-provide-enhanced-insurance-solutions-to-underserved-communities/ 2025-06-08T17:57:09+00:00 https://synopulse.com/organon-expands-dermatology-portfolio-with-acquisition-of-dermavant-and-its-vtama-cream/ 2025-06-08T17:57:01+00:00 https://synopulse.com/axcelead-ddp-and-eli-lilly-partner-for-drug-discovery-programs/ 2025-06-08T17:56:52+00:00 https://synopulse.com/nanovation-therapeutics-partners-with-novo-nordisk-to-develop-genetic-medicines-for-cardiometabolic-and-rare-diseases/ 2025-06-08T17:56:37+00:00 https://synopulse.com/corrohealth-acquired-revenue-cycle-management-business-from-navient/ 2025-06-08T17:56:27+00:00 https://synopulse.com/oncoc4-merginging-with-acroimmune/ 2025-06-08T17:56:17+00:00